References
  1. Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., … & Chen, H. D. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature579 (7798), 270-273.
  2. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., … & Niu, P. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine .
  3. ”WHO Director-General’s opening remarks at the media briefing on COVID-19” (https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020). World Health Organization (WHO) (Press release). 11 March 2020. Archived (https://web.archive.org/web/20200311212521/https://www.who.int/dg/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid-19—11-march-2020) from the original on 11 March 2020. Retrieved 10 May 2020.
  4. ”https://www.worldometers.info/coronavirus/”, Author: Worldometers.info, Publishing Date: 10 May, 2020, Place of publication: Dover, Delaware, U.S.A.
  5. World Health Organization. (2020). Infection prevention and control during health care when COVID-19 is suspected: interim guidance, 19 March 2020 (No. WHO/2019-nCoV/IPC/2020.3). World Health Organization.‏
  6. World Health Organization. (2020). Rational use of personal protective equipment for coronavirus disease (‎‎ COVID-19)‎‎ and considerations during severe shortages: interim guidance, 6 April 2020 (No. WHO/2019-nCov/IPC_PPE_use/2020.3). World Health Organization.‏
  7. Pui, C. H., Relling, M. V., Sandlund, J. T., Downing, J. R., Campana, D., & Evans, W. E. (2004). Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Annals of hematology83 , S124-6.
  8. Felice MS, Rossi JG, Gallego MS, et al.: No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy. Pediatr Blood Cancer 57 (1):47-55, 2011
  9. Rubnitz, J. E., Inaba, H., Dahl, G., Ribeiro, R. C., Bowman, W. P., Taub, J., … & Meshinchi, S. (2010). Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. The lancet oncology11 (6), 543-552.
  10. Burnett, A. K., Russell, N. H., Hills, R. K., Hunter, A. E., Kjeldsen, L., Yin, J., … & Milligan, D. (2013). Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. Journal of clinical oncology31 (27), 3360-3368.